Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drug

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 05 Oct, 13:57 UTC

The Nobel laureates “laid the foundation” for a new field of brain research, the award committee wrote. Elsewhere, Roche and CSL cut licensing deals and the FDA endorsed broader use of a Lilly medicine.

science

Sources

• T2Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drugBioPharma Dive / Healthcare Dive / MedTech Dive05 Oct, 13:57